Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Lanrun Biological Technology is a Chinese biotechnology company focused on the development and commercialization of chitosan-based medical devices and biomaterials. Founded in 2008 and headquartered in Chengdu, the company specializes in high-end medical dressings, dental materials, and gynecological health products. Their flagship products utilize the antimicrobial and regenerative properties of chitosan to treat conditions such as dermatitis, chronic wounds, and oral diseases. Lanrun maintains a strong presence in the domestic Chinese market with multiple Class II and Class III medical device registrations. The company integrates R&D, production, and sales to provide solutions for tissue repair and infection control. Their research efforts continue to expand the clinical applications of marine-derived biopolymers in regenerative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Lanrun Biological Technology.